[HTML][HTML] COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes
I Sánchez-Cerrillo, P Landete, B Aldave… - The Journal of …, 2020 - Am Soc Clin Investig
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in
infected individuals, who can either exhibit mild symptoms or progress toward a life …
infected individuals, who can either exhibit mild symptoms or progress toward a life …
[HTML][HTML] COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes
I Sánchez-Cerrillo, P Landete, B Aldave… - The Journal of …, 2020 - Am Soc Clin Investig
COVID-19 spans a wide range of symptoms, sometimes with profound immune system
involvement. How immune cell subsets change during the disease course and with disease …
involvement. How immune cell subsets change during the disease course and with disease …
[HTML][HTML] COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes
I Sánchez-Cerrillo, P Landete, B Aldave… - The Journal of …, 2020 - ncbi.nlm.nih.gov
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in
infected individuals, who can either exhibit mild symptoms or progress toward a life …
infected individuals, who can either exhibit mild symptoms or progress toward a life …
[引用][C] COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes
I Sánchez-Cerrillo, P Landete, B Aldave… - Journal of Clinical …, 2020 - cir.nii.ac.jp
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory
transitional and nonclassical monocytes | CiNii Research CiNii 国立情報学研究所 学術情報 …
transitional and nonclassical monocytes | CiNii Research CiNii 国立情報学研究所 学術情報 …
COVID-19 severity associates with pulmonary redistribution of [CD1c. sup.+] DCs and inflammatory transitional and nonclassical monocytes.
I Sanchez-Cerrillo, P Landete, B Aldave… - Journal of Clinical …, 2020 - go.gale.com
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in
infected individuals, who can either exhibit mild symptoms or progress toward a life …
infected individuals, who can either exhibit mild symptoms or progress toward a life …
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
I Sánchez-Cerrillo, P Landete, B Aldave… - The Journal of …, 2020 - europepmc.org
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in
infected individuals, who can either exhibit mild symptoms or progress toward a life …
infected individuals, who can either exhibit mild symptoms or progress toward a life …
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes
I Sánchez-Cerrillo, P Landete, B Aldave… - Journal of Clinical …, 2020 - search.proquest.com
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in
infected individuals, who can either exhibit mild symptoms or progress toward a life …
infected individuals, who can either exhibit mild symptoms or progress toward a life …
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
I Sánchez-Cerrillo, P Landete, B Aldave… - 2020 - cabidigitallibrary.org
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in
infected individuals, who can either exhibit mild symptoms or progress toward a life …
infected individuals, who can either exhibit mild symptoms or progress toward a life …
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
I Sánchez-Cerrillo, P Landete… - Journal of Clinical …, 2020 - search.ebscohost.com
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in
infected individuals, who can either exhibit mild symptoms or progress toward a life …
infected individuals, who can either exhibit mild symptoms or progress toward a life …
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes
I Sánchez-Cerrillo, P Landete… - The Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in
infected individuals, who can either exhibit mild symptoms or progress toward a life …
infected individuals, who can either exhibit mild symptoms or progress toward a life …